Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial.

In HER2-positive breast cancer, clinical outcome and sensitivity to HER2-targeted therapies are influenced by both tumor and microenvironment features. However, we are currently unable to depict the molecular heterogeneity of this disease with sufficient granularity. Here, by performing gene expression profiling in HER2-positive breast cancers from patients receiving adjuvant trastuzumab in the ALTTO clinical trial (NCT00490139), we identify and characterize five molecular subtypes associated with the risk of distant recurrence: immune-enriched, proliferative/metabolic-enriched, mesenchymal/stroma-enriched, luminal, and ERBB2-dependent.

Postpercutaneous nephrolithotomy pseudoaneurysm embolization - Immediate endovascular coil migration into the pelvicalyceal system causing obstruction.

Bleeding is the most dreaded complication after percutaneous nephrolithotomy (PCNL). We report a case of post PCNL hematuria managed with selective angioembolization of the pseudoaneurysm. During the embolization, the emolization coil along with the glue migrated into the pelvicalyceal system from the pseudoaneurysmal cavity.

Nonaqueous Synthesis of Low-Vacancy Chromium Hexacyanochromate.

Prussian blue analogues (PBAs) are a highly tunable family of materials with properties suitable for a wide variety of applications. Although their straightforward aqueous synthesis allows for the facile preparation of a diverse set of compositions, the use of water as the solvent has hindered the preparation of specific compositions with highly sought-after properties. A typical example is Cr[Cr(CN)]: its predicted strong magnetic interactions have motivated many attempts at its synthesis but with limited success.

Metabolic Choreography of Energy Substrates During DCD Heart Perfusion.

Background: The number of patients waiting for heart transplant far exceeds the number of hearts available. Donation after circulatory death (DCD) combined with machine perfusion can increase the number of transplantable hearts by as much as 48%. Emerging studies also suggest machine perfusion could enable allograft "reconditioning" to optimize outcomes.